FOI release

PAR - Glyco Bromide

Case reference FOI2025/00943

Received 2 September 2025

Published 9 October 2025

Request

Can you please provide us with the Public Assessment Reports for the following Glycopyrronium Bromide 1mg/5ml Oral Solution licences, which were granted last year: 1. PL25258/0392 - Glenmark Pharma 2. PL15764/0164 - Strandhaven Ltd t/a Somex Pharma

Response

See attached

Documents

• FOI2025_00943 (redacted).pdf (514.3 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.